Investigational Site Number :3800003

Milan 20142

0 studies enrolling now · 5 studies all time

What they study most

Colitis Ulcerative, Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, Hypercholesterolaemia, Oesophageal Adenocarcinoma, Oesophageal Squamous Cell Carcinoma, Plasma Cell Myeloma, Polymyalgia Rheumatica

Studies at this site

• A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) — Completed
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis — Running, not enrolling
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) — Completed
• An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia — Completed
• Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica — Stopped early